Cargando…
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States
SIMPLE SUMMARY: Mixed acinar neuroendocrine carcinoma of the pancreas (MANEC-P) is one of the rarest pancreatic carcinomas. Although MANEC-P is rare, it is associated with a bad prognosis. The distribution of this fatal cancer is unknown worldwide. Our contribution is expected to be a detailed under...
Autores principales: | Abdelrahman, Amro M., Yin, Jun, Alva-Ruiz, Roberto, Yonkus, Jennifer A., Leiting, Jennifer L., Lynch, Isaac T., Fogliati, Alessandro, Campbell, Nellie A., Carlson, Danielle M., Roberts, Lewis R., Gores, Gregory J., Smoot, Rory L., Graham, Rondell P., Halfdanarson, Thorvardur R., Truty, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913846/ https://www.ncbi.nlm.nih.gov/pubmed/36765798 http://dx.doi.org/10.3390/cancers15030840 |
Ejemplares similares
-
Cancer “Avatars”: Patient-Derived Xenograft Growth Correlation with Postoperative Recurrence and Survival in Pancreaticobiliary Cancer
por: Lynch, Isaac T, et al.
Publicado: (2023) -
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors
por: Gudmundsdottir, Hallbera, et al.
Publicado: (2022) -
Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
por: Ogbonna, Onyekachi Henry, et al.
Publicado: (2013) -
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
por: Alva-Ruiz, Roberto, et al.
Publicado: (2021) -
Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine
por: Leiting, Jennifer L., et al.
Publicado: (2020)